2013.6-2013.9 Post-doc in Cancer Center, Georgia Health and Science University, USA
2012.6-2013.5 Post-doc in Dept. of Radiation Oncology, University of Michigan, USA 
2007.7-Presence Physician in Dept. of Radiation Oncology, Shanghai Cancer center, Fudan University: Resident, attending Physician and Associate Professor
2004.9-2007.7 Tianjin Medical University. Ph.D.
2001.9-2004.7 Shandong Academy of Medical Science. Master
1996.9-2001.7 Binzhou Medical College. MD

Thoracic Cancer

1. Li L, Ren S, Zhang Y,et al.  Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: potential value in the clinic. Lung cancer. 2013;81(2):213-7.
2.Li L, Hu M, Zhu H, er al. Comparison of 18F-Fluoroerythronitroimidazole and 18F-fluorodeoxyglucose positron emission tomography and prognostic value in locally advanced non-small-cell lung cancer. Clin Lung Cancer. 2010;11(5):335-40.
3.Li L, Yu J, Xing L, et al. Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in nonsmall cell lung cancer. Am J Clin Oncol. 2006;29(6):628-33.
4.Li L, Yu JM, Xing LG, et al. Hypoxic imaging with 99mTc-HL91 single photon emission computed tomography in advanced nonsmall cell lung cancer. Chin Med J (Engl). 2006;119(17):1477-80.
5.Guo H, Zhu H, Xi Y, Zhang B, Li L, et al. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus. J Nucl Med. 2007;48(8):1251-8.
6.Li L, Yu JM, Sun XD, et al. Prognostic value of 9mTc-HL91 SPECT hypoxia imaging in patients with advanced NSCLC.Zhonghua Zhong Liu Za Zhi. 2007;29(2):127-30. Chinese.
7.Li L, Hu M, Yu JM, et al. Correlations of 99 Tc m-HL91 SPECT hypoxia imaging with HIF-1alpha and VEGF expression in non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi. 2009;31(9):669-73. Chinese.

2013 The First Prize of Science and Technology Award in Shandong Medical Academy
2014 The Third prize of Medical Award of Shandong Province

Wednesday Afternoon